The Valley Desk

NCT00678392 · Interventional trial

Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer

Overall registry status Completed

Phase 3

Conditions Kidney Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov